Provided by Tiger Trade Technology Pte. Ltd.

ResMed

231.52
+3.081.35%
Post-market: 231.520.00000.00%19:30 EDT
Volume:1.73M
Turnover:399.65M
Market Cap:33.40B
PE:22.20
High:234.14
Open:229.44
Low:228.54
Close:228.44
52wk High:293.81
52wk Low:180.27
Shares:144.25M
Float Shares:143.49M
Volume Ratio:1.34
T/O Rate:1.20%
Dividend:2.40
Dividend Rate:1.04%
EPS(TTM):10.43
EPS(LYR):10.43
ROE:24.27%
ROA:14.00%
PB:5.07
PE(LYR):22.20

Loading ...

ResMed CEO Michael J. Farrell sells 4,991 common shares worth $967,658.34

Reuters
·
Jun 10

ResMed Inc. Stock Falls Monday, Underperforms Market

Dow Jones
·
Jun 09

Statement of CDIs on issue - RMD-RMD.N

Reuters
·
Jun 04

Resmed Inc-Statement of Changes in Beneficial Ownership

THOMSON REUTERS
·
Jun 04

Statement of changes in beneficial ownership-RMD.N

Reuters
·
Jun 04

ResMed Inc. Stock Rises Wednesday, Outperforms Market

Dow Jones
·
Jun 04

Angelini Ventures Marks First Portfolio Company Exit as Resmed Acquires Noctrix Health for $340 Million

THOMSON REUTERS
·
Jun 03

ResMed releases investor presentation outlining connected sleep, breathing health strategy and growth outlook

Reuters
·
Jun 03

ResMed Inc. Stock Falls Tuesday, Underperforms Market

Dow Jones
·
Jun 03

ResMed Inc. Stock Falls Monday, Underperforms Market

Dow Jones
·
Jun 02

ResMed completes acquisition of Noctrix Health

Reuters
·
Jun 02

Resmed Completes Acquisition of Noctrix Health, Expanding Clinical Sleep Health Portfolio

THOMSON REUTERS
·
Jun 02

Movement Alert|ResMed Falls 5.08% in Regular Trading, Major Acquisition Announcement Sparks Market Concerns Over Integration Risks

Market Focus
·
May 30

ResMed Inc. Stock Falls Thursday, Underperforms Market

Dow Jones
·
May 29

ResMed Files 2025 Conflict Minerals Disclosure Under SEC Rules

TIPRANKS
·
May 27

Form SD-RMD.N

Reuters
·
May 27

How ResMed–Oura Wearable Sleep Data Partnership Could Reshape ResMed's (RMD) Clinical Ecosystem

Simply Wall St.
·
May 22

ResMed Inc. Stock Rises Tuesday, Outperforms Market

Dow Jones
·
May 20

Resmed Announces Participation in the 46th Annual William Blair Growth Stock Conference

GlobeNewswire
·
May 20

ResMed Targets Circadian Data With New Wearable Trial: What Investors Should Watch

TIPRANKS
·
May 20